Oscar Health Inc (OSCR) Q3 2026 Earnings Call Highlights: Record Profitability, Raised
Oscar Health (OSCR) reported Q3 2026 earnings with record profitability and raised guidance. Membership declined due to CMS reviews, with more disenrollments expected. Q4 SG&A expenses are projected to rise due to seasonal spending. CEO Mark Bertolini and CFO Richard Blackley discussed market share gains, utilization trends, and CMS program integrity initiatives. The company anticipates stable membership and market growth despite competitive pressures and regulatory uncertainties.
How this was made
The 30-second read
Why it matters
The guidance revision introduces higher expense expectations and membership churn risk, which could pressure the stock in the near term.
Market read
First disclosure of Q3 results and Q4 guidance for Oscar Health, affecting its valuation and peer comparison.
What to watch
AI‑driven efficiency gains and new product launches like RetireEase may improve long‑term profitability.
Background
Oscar Health provided its Q3 2026 earnings call highlights, noting record profitability, SG&A improvements, and updated Q4 guidance.
Ticker impact
Q3 earnings call disclosed record profitability and raised Q4 guidance, including a $250M risk adjustment benefit and higher SG&A expense.
likely downside as investors price in higher SG&A and potential enrollment declines
The call highlighted a step‑up in SG&A, membership churn risk, and a large risk‑adjustment benefit that may not fully offset cost pressures.
Market effects
Signals potential margin pressure for health‑insurance peers facing CMS eligibility reviews.
US health‑insurance market may see modest re‑rating.
Limited to U.S. insurers; no broader macro effect.
Counterpoint
The $250M risk‑adjustment benefit could offset cost increases, supporting upside if enrollment stabilizes.
Key entities
- companyOscar Health Inc
U.S. health‑insurance provider (ticker OSCR).
